CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.35
+0.04 (0.55%)
At close: Feb 26, 2026, 4:00 PM EST
7.40
+0.05 (0.68%)
After-hours: Feb 26, 2026, 7:00 PM EST
CorMedix Revenue
CorMedix had revenue of $104.28M in the quarter ending September 30, 2025, with 810.22% growth. This brings the company's revenue in the last twelve months to $214.30M, up 1,770.65% year-over-year. In the year 2024, CorMedix had annual revenue of $43.47M.
Revenue (ttm)
$214.30M
Revenue Growth
+1,770.65%
P/S Ratio
2.70
Revenue / Employee
$3,296,980
Employees
65
Market Cap
579.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43.47M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 65.41K | -125.53K | -65.74% |
| Dec 31, 2021 | 190.94K | -48.30K | -20.19% |
| Dec 31, 2020 | 239.23K | -44.04K | -15.55% |
| Dec 31, 2019 | 283.27K | -146.53K | -34.09% |
| Dec 31, 2018 | 429.80K | 100.47K | 30.51% |
| Dec 31, 2017 | 329.33K | 105.22K | 46.95% |
| Dec 31, 2016 | 224.11K | 13.98K | 6.65% |
| Dec 31, 2015 | 210.13K | 20.86K | 11.02% |
| Dec 31, 2014 | 189.27K | 187.27K | 9,358.97% |
| Dec 31, 2013 | 2.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fulcrum Therapeutics | 80.00M |
| MeiraGTx Holdings | 27.42M |
| Ocugen | 5.37M |
| Allogene Therapeutics | 22.00K |
| Altimmune | 20.00K |
CRMD News
- 12 days ago - CorMedix Inc. (CRMD) Analyst/Investor Day Transcript - Seeking Alpha
- 14 days ago - CorMedix to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 24 days ago - CorMedix Therapeutics Announces Share Repurchase Program - GlobeNewsWire
- 4 weeks ago - CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 - GlobeNewsWire
- 6 weeks ago - CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Why is CorMedix stock crashing today: is it worth buying on the dip? - Invezz
- 7 weeks ago - CorMedix Therapeutics Announces Leadership and Board Updates - GlobeNewsWire